A Wearable Targeted Ultrasound Device to Treat Rheumatoid Arthritis

Rheumatoid arthritis affects about 1% of the world’s population. Claire Kaiser’s project aims to develop a wearable, noninvasive device for targeted ultrasound of neural pathways within the spleen combined with noninvasive electrical stimulation of the vagus nerve to treat rheumatoid arthritis. The project vision is to create a start-up company in Minnesota to develop novel autonomic neuromodulation technologies that combine targeted ultrasound and electrical stimulation for treating rheumatoid arthritis patients and other pain and autoimmune conditions.

Discoveries Through Industry Partnerships Fellow: Claire Kaiser, Biomedical Engineering

Mentor: Hubert Lim, Otolaryngology

Industry Partner: The Ultran Group, Anuj Bhardwaj